25 Participants Needed

PluroGel vs Standard Dressing for Burns

JG
Overseen ByJustin Gawaziuk, MSc
Age: 18+
Sex: Any
Trial Phase: Phase 1 & 2
Sponsor: University of Manitoba
Stay on Your Current MedsYou can continue your current medications while participating
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

Burn injuries can result in long term physical and mental sequelae, not only from the scarring but also the painful dressings. The standard of care today remains use of antibiotic topical dressings while awaiting demarcation of the burn depth, with surgical excision and grafting for deep partial thickness and full thickness areas. Demarcation can be appreciated on admission for full thickness burns but is often a prolonged process that can last weeks. The clinical evaluation of the depth of the burn is a complex decision that often is made more challenging by the presence of the proteinaceous pseudoeschar and the coagulated dermis itself. Surgical debridement is relatively 'coarse' and by its very nature requires removal of a thin layer of viable tissue to reach the level that is vascularized enough to support a skin graft. There has been growing interest in the use of adjuncts to reduce the amount tissue debrided and potentially reduce the need for surgery itself. Operatively, there have been some reports that use of hydro-dissection devices (Versajet™) may allow a more controlled debridement, resulting in less viable tissue being sacrificed. There is also a growing experience with enzymatic debridement, especially with Bromolein, derived from Pineapple (NexoBrid®). Neither of these have been shown to definitively improve care in randomized controlled trials, (RCTs) and there is suggestion that in some settings may actually cause harm.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment PluroGel for burns?

Research on hydrogel burn dressings, like PluroGel, shows they are effective in managing burns by combining with other materials to improve healing. Additionally, similar treatments with antimicrobial properties, such as silver-containing dressings, have been shown to prevent infection and aid in healing partial-thickness burns.12345

How does PluroGel differ from standard treatments for burns?

PluroGel is a hydrogel-based dressing that offers a moist environment for wound healing, which can be beneficial for burns. Unlike traditional dressings that may shrink or lose integrity when wet, hydrogels like PluroGel maintain their structure and can be combined with antimicrobial agents to prevent infection.23467

Eligibility Criteria

This trial is for individuals with partial thickness burns on the face or one limb that require hospital admission. It's not suitable for those with full-thickness burns, electrical or chemical burns, malnutrition, previous excisions elsewhere, or if more than 30% of their body is burned.

Inclusion Criteria

I have burns on my face or one limb that needed hospital care.

Exclusion Criteria

Over 30% of my body has been burned.
I had surgery at a different hospital.
Patients with pre-existing malnutrition
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants receive either PluroGel® or standard topical dressing for burn injuries

1-14 days
Dressing changes every Monday, Wednesday, and Friday

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • PluroGel
  • Standard dressing
Trial OverviewThe study compares PluroGel®, a new type of burn dressing, to standard antibiotic dressings used in burn care. The goal is to see if PluroGel® can improve healing and reduce the need for surgical removal of damaged tissue.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Test dressingExperimental Treatment1 Intervention
A 0.5 cm layer of PluroGel® followed by the above standard dressing. In addition, this will be covered with moistened gauze, kept moist twice daily. (The additional factors are the use of PluroGel® and moistened gauze. Standard dressing will continue to be used.)
Group II: Standard dressingActive Control1 Intervention
Topical antibiotic ointment (Polysporin™ or formulary equivalent) and non-adherent petrolatum fine-meshed gauze (ADAPTIC™) applied every Monday, Wednesday and Friday (or equivalent).

PluroGel is already approved in United States for the following indications:

🇺🇸
Approved in United States as PluroGel Burn and Wound Dressing for:
  • Management of full and partial thickness wounds including surgically created wounds, dermal ulcers (pressure ulcers), leg ulcers (diabetic foot ulcers), superficial wounds, first degree burns, partial thickness burns, and donor sites.
  • Minor cuts, minor burns, and minor lacerations (OTC)

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Manitoba

Lead Sponsor

Trials
628
Recruited
209,000+

Medline Industries

Industry Sponsor

Trials
46
Recruited
23,000+

Findings from Research

The AQUACEL Hydrofiber Dressing containing ionic silver demonstrated strong antimicrobial properties against a variety of burn wound pathogens, including antibiotic-resistant bacteria, during a 14-day test period.
This dressing not only helps prevent infection but also effectively manages fluid exudate, making it a valuable option for treating partial-thickness burns.
Microbicidal properties of a silver-containing hydrofiber dressing against a variety of burn wound pathogens.Bowler, PG., Jones, SA., Walker, M., et al.[2022]
The chitosan-based silver dressing maintained its size and integrity when wet, unlike traditional burn dressings, which often shrink and disintegrate, making it a promising alternative for burn treatment.
In a pilot study involving 12 partial-thickness burns in 10 children, the wounds healed within an average of 8.3 days without any infections, indicating the dressing's efficacy and safety in managing burn wounds.
The use of a chitosan dressing with silver in the management of paediatric burn wounds: a pilot study.Massand, S., Cheema, F., Brown, S., et al.[2022]
Hydrogel burn dressings are highlighted as one of the most effective options for treating burns, showcasing their advantages when combined with other materials.
The review discusses the ongoing research and development trends in synthetic burn dressings, indicating a focus on improving their efficacy and safety for better patient outcomes.
[Progress in the studies on hydrogel burn dressings].Luo, J., Fang, G., Xie, X., et al.[2004]

References

Microbicidal properties of a silver-containing hydrofiber dressing against a variety of burn wound pathogens. [2022]
The use of a chitosan dressing with silver in the management of paediatric burn wounds: a pilot study. [2022]
[Progress in the studies on hydrogel burn dressings]. [2004]
Comparison of the efficacy of silver-based antimicrobial burn dressings in a porcine model of burn wounds. [2021]
Topical Antimicrobials in Burn Care: Part 1-Topical Antiseptics. [2020]
Principles of burn dressings. [2019]
Outpatient burns: a prospective study. [2013]